PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38 | -81.9% | 14,262 | -71.3% | 0.00% | -85.7% |
| Q4 2022 | $210 | -99.9% | 49,760 | +144.1% | 0.03% | +55.6% |
| Q2 2021 | $187,000 | +12.7% | 20,384 | +25.7% | 0.02% | 0.0% |
| Q4 2020 | $166,000 | +44.3% | 16,213 | +52.4% | 0.02% | +100.0% |
| Q3 2019 | $115,000 | -66.9% | 10,637 | -37.7% | 0.01% | -52.6% |
| Q4 2018 | $347,000 | -47.5% | 17,065 | +209.2% | 0.02% | -42.4% |
| Q3 2017 | $661,000 | – | 5,519 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |